Skip to main content
Watch Insiders

Corporate insider profile

Thomas Catinazzo Insider Trades

Latest reported as Chief Financial Officer of Relay Therapeutics, Inc. (RLAY).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,791,981.93
Latest transaction
Oct 6, 2026

Affiliated corporations

Reported company relationships

RLAYLatest reported

Relay Therapeutics, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 6, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale17,717$18.59$329,322
Sep 8, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale17,717$18.94$335,560
Aug 14, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale17,717$19.74$349,734
Jul 28, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale1,459$18.61$27,152
Jul 6, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale17,717$18.69$331,131
Jun 22, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale187,163$16.97$3,176,867
May 14, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale17,717$12.86$227,841
Apr 28, 2026Relay Therapeutics, Inc. (RLAY)Chief Financial OfficerSale972$14.79$14,376